Ray M. Koo
Hematology Oncology | Hematology | Oncology
825 Eastlake Ave E
Seattle, WA 98109
Seattle, WA 98109
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Post-transplant anti-thymocyte globulin exposure predicts graft-versus-host disease and donor chimerism outcomes in reduced intensity conditioning allogeneic stem cell transplantation.
Journal: Frontiers in immunology
Published: May 12, 2026
Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years.
Journal: Nature communications
Published: May 31, 2024
A phase 1 dose-escalation study of low-dose lenalidomide maintenance post-allogeneic stem cell transplantation for high-risk acute myeloid leukaemia or myelodysplastic syndrome.
Journal: Bone marrow transplantation
Published: September 14, 2023
Self-reliance or the generosity of others?: autologous versus allogeneic stem cell transplantation in high-risk Hodgkin lymphoma.
Journal: Leukemia & lymphoma
Published: October 22, 2021
A Wolf in Sheep's clothing: A case report series of oral manifestations of multiple myeloma.
Journal: Australian dental journal
Published: November 20, 2020
Genetic and Molecular Testing in Thrombosis and Hemostasis: Informing Surveillance, Treatment, and Prognosis.
Journal: Seminars in thrombosis and hemostasis
Published: May 02, 2019
Successful treatment of central nervous system myeloma manifesting as cauda equina nodules with intrathecal chemotherapy, lenalidomide and dexamethasone.
Journal: BMJ case reports
Published: November 11, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026